Vanguard Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.9M Sell
1,011,783
-362,125
-26% -$11.1M ﹤0.01% 2352
2025
Q1
$37.1M Sell
1,373,908
-172,782
-11% -$4.66M ﹤0.01% 2226
2024
Q4
$55.5M Sell
1,546,690
-55,795
-3% -$2M ﹤0.01% 2120
2024
Q3
$60.8M Buy
1,602,485
+27,549
+2% +$1.04M ﹤0.01% 2093
2024
Q2
$71.3M Sell
1,574,936
-6,756
-0.4% -$306K ﹤0.01% 2004
2024
Q1
$76.7M Sell
1,581,692
-1,050
-0.1% -$50.9K ﹤0.01% 1991
2023
Q4
$84.8M Buy
1,582,742
+15,560
+1% +$834K ﹤0.01% 1945
2023
Q3
$91.9M Buy
1,567,182
+38,533
+3% +$2.26M ﹤0.01% 1850
2023
Q2
$96.4M Sell
1,528,649
-14,305
-0.9% -$902K ﹤0.01% 1876
2023
Q1
$97.1M Buy
1,542,954
+8,044
+0.5% +$506K ﹤0.01% 1847
2022
Q4
$81.7M Buy
1,534,910
+54,227
+4% +$2.88M ﹤0.01% 1917
2022
Q3
$83M Sell
1,480,683
-16,700
-1% -$936K ﹤0.01% 1910
2022
Q2
$108M Sell
1,497,383
-13,469
-0.9% -$975K ﹤0.01% 1771
2022
Q1
$120M Buy
1,510,852
+12,121
+0.8% +$963K ﹤0.01% 1841
2021
Q4
$152M Sell
1,498,731
-34,577
-2% -$3.5M ﹤0.01% 1757
2021
Q3
$141M Buy
1,533,308
+41,449
+3% +$3.82M ﹤0.01% 1789
2021
Q2
$153M Sell
1,491,859
-3,154
-0.2% -$323K ﹤0.01% 1772
2021
Q1
$146M Buy
1,495,013
+67,353
+5% +$6.57M ﹤0.01% 1750
2020
Q4
$110M Buy
1,427,660
+34,466
+2% +$2.66M ﹤0.01% 1785
2020
Q3
$103M Buy
1,393,194
+35,259
+3% +$2.6M ﹤0.01% 1677
2020
Q2
$99.7M Sell
1,357,935
-35,413
-3% -$2.6M ﹤0.01% 1678
2020
Q1
$80.5M Buy
1,393,348
+55,423
+4% +$3.2M ﹤0.01% 1649
2019
Q4
$105M Sell
1,337,925
-366
-0% -$28.7K ﹤0.01% 1725
2019
Q3
$91.5M Sell
1,338,291
-97,577
-7% -$6.67M ﹤0.01% 1777
2019
Q2
$114M Sell
1,435,868
-28,349
-2% -$2.25M ﹤0.01% 1679
2019
Q1
$123M Buy
1,464,217
+112,761
+8% +$9.46M ﹤0.01% 1641
2018
Q4
$159M Buy
1,351,456
+105,649
+8% +$12.4M 0.01% 1393
2018
Q3
$150M Buy
1,245,807
+120,709
+11% +$14.6M 0.01% 1580
2018
Q2
$130M Buy
1,125,098
+91,484
+9% +$10.5M 0.01% 1641
2018
Q1
$88.8M Sell
1,033,614
-4,876
-0.5% -$419K ﹤0.01% 1779
2017
Q4
$76.9M Buy
1,038,490
+22,816
+2% +$1.69M ﹤0.01% 1849
2017
Q3
$58.6M Buy
1,015,674
+35,948
+4% +$2.07M ﹤0.01% 1963
2017
Q2
$62.8M Buy
979,726
+25,136
+3% +$1.61M ﹤0.01% 1902
2017
Q1
$55M Buy
954,590
+36,655
+4% +$2.11M ﹤0.01% 1963
2016
Q4
$56.2M Sell
917,935
-21,459
-2% -$1.31M ﹤0.01% 1911
2016
Q3
$65M Sell
939,394
-118,044
-11% -$8.17M ﹤0.01% 1807
2016
Q2
$58.9M Sell
1,057,438
-243,138
-19% -$13.5M ﹤0.01% 1826
2016
Q1
$79M Buy
1,300,576
+22,090
+2% +$1.34M 0.01% 1629
2015
Q4
$81.7M Buy
1,278,486
+20,418
+2% +$1.3M 0.01% 1599
2015
Q3
$84.3M Buy
1,258,068
+69,514
+6% +$4.66M 0.01% 1559
2015
Q2
$81.2M Buy
1,188,554
+204,352
+21% +$14M 0.01% 1661
2015
Q1
$54.7M Buy
984,202
+134,826
+16% +$7.49M ﹤0.01% 1867
2014
Q4
$43.6M Buy
849,376
+50,984
+6% +$2.62M ﹤0.01% 1900
2014
Q3
$29.4M Sell
798,392
-85,228
-10% -$3.14M ﹤0.01% 2062
2014
Q2
$34.5M Sell
883,620
-125,036
-12% -$4.89M ﹤0.01% 2006
2014
Q1
$38M Buy
1,008,656
+14,200
+1% +$535K ﹤0.01% 1938
2013
Q4
$37.6M Buy
994,456
+37,910
+4% +$1.43M ﹤0.01% 1917
2013
Q3
$41.5M Buy
956,546
+86,448
+10% +$3.75M ﹤0.01% 1827
2013
Q2
$31.5M Buy
+870,098
New +$31.5M ﹤0.01% 1892